Teva whistleblower says SEC is taking too long to determine award
A purported whistleblower in Teva Pharmaceutical’s FCPA case says the SEC has “unreasonably delayed” ruling on whether his tip should be granted an award.
To read more
Subscribe to Global Investigations Review
Subscribe and start reading now
Global Investigations Review (GIR) is the hub for global coverage of corporate investigations and their aftermath. Keep up to date with significant developments in the corporate investigations world.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10